Related Experiment Video
Updated: Feb 16, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Kv4.3 expression reverses ICa remodeling in ventricular myocytes of heart failure
Jun Cheng1, Jianlei Cao1, Xingchen Jiang1
1Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.
Insights
Restoring Kv4.3 in heart failure (HF) reverses abnormal L-type calcium channel (LTCC) current remodeling by inhibiting membrane-associated CaMKII. This suggests Kv4.3 is a potential therapy for calcium dysregulation in HF.
Area of Science:
- Cardiology
- Molecular Biology
- Physiology
Background:
- Calcium channel (LTCC) current (ICa) remodeling, driven by Ca2+/calmodulin-dependent protein kinase II (CaMKII), disrupts calcium homeostasis in heart failure (HF).
- Kv4.3 proteins are crucial for regulating membrane-associated CaMKII activity in ventricular myocytes.
Purpose of the Study:
- To investigate the effect of in vivo Kv4.3 expression on ICa in left ventricular (LV) myocytes from HF patients.
Main Methods:
- Heart failure (HF) was induced in a pressure-overload model via thoracic aortic banding.
- Kv4.3 expression was achieved through Adenovirus-mediated (Ad-Kv4.3) injection into the LV myocardium.
- ICa was measured in subepicardial (SEP) and subendocardial (SEN) myocytes using whole-cell patch clamp.
Main Results:
- Kv4.3 expression reduced both overall and membrane-associated CaMKII autophosphorylation.
- ICa density was proportionally reduced in SEP and SEN myocytes, maintaining the transmural gradient.
- Kv4.3 expression accelerated ICa recovery from inactivation and restored frequency-dependent Ca2+-induced ICa facilitation.
Conclusions:
- Kv4.3 expression effectively reverses ICa remodeling in the failing ventricle by inhibiting membrane-associated CaMKII.
- Restoring Kv4.3 presents a potential therapeutic strategy for addressing calcium dysregulation in heart failure.
Background:
Ca2+/calmodulin-dependent protein kinase II (CaMKII)-dependent L-type calcium channel (LTCC) current (ICa) remodeling is an important contributor to the disruption of calcium homeostasis in heart failure (HF). We have reported that Kv4.3 proteins play an important role in delicate regulation of the membrane-associated CaMKII activity in ventricular myocytes. Here, we investigated the effect of in vivo Kv4.3 expression on ICa in HF left ventricular (LV) myocytes.
Results:
Kv4.3 expression reduced overall CaMKII autophosphorylation with much greater reduction in the membrane compartmentalized CaMKII activity. ICa density in subepicardial (SEP) and subendocardial (SEN) myocytes was proportionately reduced, without changing the transmural gradient. While the time course of ICa decay was hastened, the voltage-dependence of ICa activation and inactivation, however, remained unchanged. ICa recovery from inactivation was significantly accelerated. In line with the partial inhibition of CaMKII, the frequency-dependent Ca2+-induced ICa facilitation was recovered in the HF myocytes transfected with Kv4.3.
Materials And Methods:
Pressure-overload HF was induced by thoracic aortic banding. Kv4.3 expression was achieved by Ad-Kv4.3 injection in the LV myocardium. ICa was recorded in dissociated SEP and SEN myocytes using whole-cell patch clamp method.
Conclusions:
Kv4.3 expression in HF ventricle can effectively reverse ICa remodeling via inhibition of the membrane-associated CaMKII, pointing to Kv4.3 restoration as a potential therapeutic approach for the disordered calcium regulation in HF.
More Related Videos
05:04In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
Published on: February 22, 2022
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure